Literature DB >> 18971788

Unusual presentation of metastatic amelanotic melanoma of unknown primary origin as a solitary breast lump.

Somak Roy1, Kajal Dhingra, Shramana Mandal, Nita Khurana.   

Abstract

Breast is an uncommon site for metastasis from other malignancies especially melanomas. A 40-year-old lady presented with a rapidly growing, painless, solitary breast lump for 3 months. Past history was unremarkable for skin lesions, biopsy or any surgery. The lump was hard and freely mobile with normal overlying skin, nipple, and areola. Careful examination of the skin did not reveal any lesion. Grossly the tumor was partially circumscribed and gray white. Microscopically, a highly cellular lesion was seen showing nests and sheets of large anaplastic cells with atypical mitotic figures without any evidence of cytoplasmic pigment. Immunoreactivity for S-100 and HMB-45, confirmed the diagnosis of amelanotic melanoma. It is important to be aware of this atypical presentation of amelanotic melanoma in the breast and to utilize immunohistochemistry to differentiate from other commoner high-grade malignant tumors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18971788     DOI: 10.1097/CMR.0b013e328317f04b

Source DB:  PubMed          Journal:  Melanoma Res        ISSN: 0960-8931            Impact factor:   3.599


  3 in total

1.  Amelanotic melanoma masquerading as a superficial small round cell tumor: a diagnostic challenge.

Authors:  Archana Shetty; Savitha Anil Kumar; V Geethamani; Mudasser Rehan
Journal:  Indian J Dermatol       Date:  2014-11       Impact factor: 1.494

2.  Diagnostic Delays in Metastatic Amelanotic Melanoma Presenting as Breast Pain.

Authors:  Tiffanie Do; Raisa Epistola; Duong T Hua; Maria M Taylor; Rose Venegas
Journal:  Am J Case Rep       Date:  2020-08-05

Review 3.  Surgery on primary melanoma of the breast.

Authors:  Qi Huang; Xiao-Hua Zhang; Ling-Ji Guo; Yu-Jun He
Journal:  Transl Cancer Res       Date:  2019-10       Impact factor: 1.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.